Drug Trials News
Most Popular Drug Trials Story
Who's next on the biotech buyout hit list?
Now that Biogen Idec is in play, the analysts are on the lookout for the next big acquisition target. Bear Stearns' Mark... Read more...
Latest Headlines
- August 21, 2008
- June 16, 2008
- June 10, 2008
- June 6, 2008
- June 3, 2008
- May 28, 2008
- May 22, 2008
- May 16, 2008
- May 16, 2008
- May 6, 2008
- April 29, 2008
- April 28, 2008
- April 23, 2008
- April 18, 2008
- April 17, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
